• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于口服药物单指数终末相标准化识别的提议。

Proposal for a standardised identification of the mono-exponential terminal phase for orally administered drugs.

作者信息

Scheerans Christian, Derendorf Hartmut, Kloft Charlotte

机构信息

Department of Clinical Pharmacy, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.

出版信息

Biopharm Drug Dispos. 2008 Apr;29(3):145-57. doi: 10.1002/bdd.596.

DOI:10.1002/bdd.596
PMID:18098336
Abstract

The area under the plasma concentration-time curve from time zero to infinity (AUC(0-inf)) is generally considered to be the most appropriate measure of total drug exposure for bioavailability/bioequivalence studies of orally administered drugs. However, the lack of a standardised method for identifying the mono-exponential terminal phase of the concentration-time curve causes variability for the estimated AUC(0-inf). The present investigation introduces a simple method, called the two times t(max) method (TTT method) to reliably identify the mono-exponential terminal phase in the case of oral administration. The new method was tested by Monte Carlo simulation in Excel and compared with the adjusted r squared algorithm (ARS algorithm) frequently used in pharmacokinetic software programs. Statistical diagnostics of three different scenarios, each with 10,000 hypothetical patients showed that the new method provided unbiased average AUC(0-inf) estimates for orally administered drugs with a monophasic concentration-time curve post maximum concentration. In addition, the TTT method generally provided more precise estimates for AUC(0-inf) compared with the ARS algorithm. It was concluded that the TTT method is a most reasonable tool to be used as a standardised method in pharmacokinetic analysis especially bioequivalence studies to reliably identify the mono-exponential terminal phase for orally administered drugs showing a monophasic concentration-time profile.

摘要

从零时间到无穷大的血浆浓度-时间曲线下面积(AUC(0-inf))通常被认为是口服给药药物生物利用度/生物等效性研究中衡量药物总暴露量的最合适指标。然而,缺乏一种标准化方法来识别浓度-时间曲线的单指数终末相,导致估算的AUC(0-inf)存在变异性。本研究引入了一种简单的方法,称为两次t(max)法(TTT法),用于在口服给药情况下可靠地识别单指数终末相。该新方法在Excel中通过蒙特卡洛模拟进行了测试,并与药代动力学软件程序中常用的调整后r平方算法(ARS算法)进行了比较。对三种不同场景(每种场景有10000名虚拟患者)的统计诊断表明,对于最大浓度后呈单相浓度-时间曲线的口服给药药物,新方法提供了无偏的平均AUC(0-inf)估计值。此外,与ARS算法相比,TTT法通常为AUC(0-inf)提供更精确的估计值。得出的结论是,TTT法是一种非常合理的工具,可作为药代动力学分析尤其是生物等效性研究中的标准化方法,用于可靠地识别呈单相浓度-时间曲线的口服给药药物的单指数终末相。

相似文献

1
Proposal for a standardised identification of the mono-exponential terminal phase for orally administered drugs.关于口服药物单指数终末相标准化识别的提议。
Biopharm Drug Dispos. 2008 Apr;29(3):145-57. doi: 10.1002/bdd.596.
2
[Value of the theory of the optimal sampling scheme for bioequivalence studies].[生物等效性研究中最优抽样方案理论的价值]
Therapie. 1993 Jan-Feb;48(1):7-13.
3
Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.70毫克阿仑膦酸钠两种口服制剂的生物利用度和生物等效性:在健康韩国成年男性志愿者中进行的开放标签、随机、两周期交叉比较。
Clin Ther. 2009 May;31(5):1037-45. doi: 10.1016/j.clinthera.2009.05.001.
4
A simple pharmacokinetics subroutine for modeling double peak phenomenon.一种用于模拟双峰现象的简单药代动力学子程序。
Biopharm Drug Dispos. 2006 Apr;27(3):119-24. doi: 10.1002/bdd.492.
5
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.比较仿制药和创新药:对美国食品药品监督管理局12年生物等效性数据的综述
Ann Pharmacother. 2009 Oct;43(10):1583-97. doi: 10.1345/aph.1M141. Epub 2009 Sep 23.
6
Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers.
Clin Exp Hypertens. 2008 Feb;30(2):95-108. doi: 10.1080/10641960801944249.
7
Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).生物等效性试验的计算机模拟:具有首过肝代谢的BCS药物中设计和分析物的选择:线性动力学(I)
Eur J Pharm Sci. 2009 Jan 31;36(1):137-46. doi: 10.1016/j.ejps.2008.10.014. Epub 2008 Nov 5.
8
Optimal sampling times in bioequivalence tests.
J Biopharm Stat. 2000 Feb;10(1):31-44. doi: 10.1081/BIP-100101011.
9
A SAS/IML program for simulating pharmacokinetic data.
Comput Methods Programs Biomed. 2005 Apr;78(1):39-60. doi: 10.1016/j.cmpb.2004.10.007.
10
Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.两种萘普生钠/对乙酰氨基酚口服片剂和两种口服混悬剂的生物利用度:在健康墨西哥成年受试者中进行的单剂量、随机、开放标签、两阶段交叉比较。
Clin Ther. 2009 Feb;31(2):399-410. doi: 10.1016/j.clinthera.2009.02.002.

引用本文的文献

1
Proposal for defining the relevance of drug accumulation derived from single dose study data for modified release dosage forms.关于定义从单剂量研究数据得出的药物蓄积对缓释剂型相关性的建议。
Biopharm Drug Dispos. 2015 Mar;36(2):93-103. doi: 10.1002/bdd.1923. Epub 2015 Jan 21.